Form 4: HealthStream Director Gifts Shares Under 10b5-1 Plan
Insider Transaction Report
HealthStream Inc. Director Deborah Taylor Tate reported gifting 40 shares of common stock, reducing her direct beneficial ownership to 21,945 shares, under a pre-planned Rule 10b5-1 arrangement.
Summary
- Director Deborah Taylor Tate reported a change in beneficial ownership of HealthStream Inc. (HSTM) common stock.
- The transaction involved the disposition of 40 shares of common stock.
- The transaction occurred on December 1, 2025, and was categorized as a gift (Transaction Code G) with a price of $0 per share.
- Following this transaction, Deborah Taylor Tate directly beneficially owns 21,945 shares of HealthStream Inc. common stock.
- The disposition was made pursuant to a Rule 10b5-1 plan, indicating a pre-scheduled transaction.
Sentiment
Score: 5
Explanation: The filing reports a pre-planned gift of a small number of shares by a director under a Rule 10b5-1 plan. This is a routine insider transaction and does not typically carry strong positive or negative sentiment regarding the company's immediate prospects.
Positives
- The transaction was a gift, which typically does not imply a negative outlook on the company's future performance by the insider, unlike a sale.
- The disposition was executed under a Rule 10b5-1 plan, suggesting a pre-planned action rather than an immediate, discretionary reaction to market conditions or non-public information.
Negatives
- A director's disposition of shares, even as a gift, results in a reduction of their direct equity stake in the company.
Risks
- While a gift, any reduction in insider ownership could be perceived by some investors as a slight decrease in alignment between management and shareholder interests, though this is mitigated by the gift nature and 10b5-1 plan.
Future Outlook
The filing indicates a pre-planned disposition of shares by a director on December 1, 2025, under a Rule 10b5-1 plan. This suggests a structured approach to managing personal equity holdings rather than a reaction to immediate company performance or market conditions.
Industry Context
This filing is a routine insider transaction report and does not provide specific industry context or trends. It reflects an individual director's equity management rather than broader industry developments.
Stakeholder Impact
- Shareholders: A minor reduction in director ownership, but the gift nature and execution under a 10b5-1 plan mitigate any significant negative interpretation regarding management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 12/01/2025 | Date of disposition of 40 shares of common stock by Director Deborah Taylor Tate. |
| 12/02/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC. |
Recommendation
holdThe disposition of 40 shares as a gift by a director, executed under a Rule 10b5-1 plan, is a routine insider transaction and does not provide sufficient new information to warrant a change in investment recommendation. The small number of shares involved further limits its significance.
Keywords
HealthStream, HSTM, Insider Transaction, Form 4, Director, Stock Gift, Beneficial Ownership, 10b5-1 Plan, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.